Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis

Código QR

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis

Sahil Sekhon, Caleb Jeon, Mio Nakamura, Di Yan, Ladan Afifi, Tina Bhutani, Ethan Levin Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA Abstract: Psoriasis vulgaris is a chronic, immune-mediated systemic...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sekhon S, Jeon C, Nakamura M, Yan D, Afifi L, Bhutani T, Levin E
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	ixekizumab biologics psoriasis IL-17 anti-IL-17 Dermatology RL1-803
Acceso en línea:	https://doaj.org/article/65c0789b2d8f4e359509330c849afc5f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Secukinumab in the treatment of psoriasis: patient selection and perspectives
por: Yang EJ, et al.
Publicado: (2018)

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
por: Liu L, et al.
Publicado: (2016)

Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
por: el Hayderi L, et al.
Publicado: (2016)

Generalized tinea versicolor following initiation of ixekizumab therapy
por: Haroon Sayed Alam, BS, et al.
Publicado: (2021)

Targeting IL-23 in psoriasis: current perspectives
por: Fotiadou C, et al.
Publicado: (2018)

Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
por: Beck KM, et al.
Publicado: (2018)

Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
por: Machado Á, et al.
Publicado: (2018)

Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study
por: Yuliya Lytvyn, PhD, et al.
Publicado: (2022)

Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial
por: Luis Puig, et al.
Publicado: (2021)

Clinical evidence of therapy for genital psoriasis by biologic agents
por: Evgeny V. Sokolovskiy, et al.
Publicado: (2021)

Biologic Treatments of Psoriasis: An Update for the Clinician
por: Brownstone ND, et al.
Publicado: (2021)

The new external drug for the treatment of psoriasis based on inhibition of serine proteases
por: Alexander S. Zhukov, et al.
Publicado: (2021)

Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris
por: Strohbuecker L, et al.
Publicado: (2019)

The Role of IL-17 Cytokines in Psoriasis
por: Mosca M, et al.
Publicado: (2021)

Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
por: Hampton P, et al.
Publicado: (2021)

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study
por: Riccardo G. Borroni, et al.
Publicado: (2021)

Gallic Acid Ameliorates Atopic Dermatitis-Like Skin Inflammation Through Immune Regulation in a Mouse Model
por: Hu G, et al.
Publicado: (2021)

Risankizumab for Plaque and Guttate Psoriasis in a Patient With IgA-Related Glomerulonephritis
por: Annunziata Dattola, et al.
Publicado: (2021)

Literature Overview of the IL-17 Inhibition from Psoriasis to COVID-19
por: Zou Y, et al.
Publicado: (2021)

Pro-Tumor and Anti-Tumor Functions of IL-17 and of TH17 Cells in Tumor Microenvironment
por: Gulubova M., et al.
Publicado: (2016)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi A, et al.
Publicado: (2019)

Pustular psoriasis: pathophysiology and current treatment perspectives
por: Benjegerdes KE, et al.
Publicado: (2016)

Diagnosis and screening of patients with generalized pustular psoriasis
por: Ly K, et al.
Publicado: (2019)

Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability
por: Abrouk M, et al.
Publicado: (2016)

Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
por: Mahé E
Publicado: (2020)

Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
por: Aimilios Lallas, et al.
Publicado: (2016)

Updates on the Treatment of Erythrodermic Psoriasis
por: Lo Y, et al.
Publicado: (2021)

Psoriasis and alcohol
por: Svanström C, et al.
Publicado: (2019)

Tacrolimus for the management of psoriasis: clinical utility and place in therapy
por: Malecic N, et al.
Publicado: (2016)

The Unmet Need for Clinical Guidelines on the Management of Patients with Plaque Psoriasis in Africa and the Middle East
por: Steinhoff M, et al.
Publicado: (2020)

REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model
por: Shangyi Wang, et al.
Publicado: (2021)

Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India
por: Budamakuntla L, et al.
Publicado: (2019)

Psoriasis and uveitis: links and risks
por: Fotiadou C, et al.
Publicado: (2019)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
por: Chiricozzi A, et al.
Publicado: (2019)

Differentiation of pityriasis rubra pilaris from plaque psoriasis by dermoscopy
por: Abhijeet Kumar Jha, et al.
Publicado: (2018)

Psoriasis: Targets and Therapy
Publicado: (2012)

Monitoring treatment response in psoriasis: current perspectives on the clinical utility of reflectance confocal microscopy
por: Agozzino M, et al.
Publicado: (2017)

Oyster-shaped hyperkeratotic plaques on the penis
por: Engin Sezer, et al.
Publicado: (2015)

Management of scalp psoriasis: current perspectives
por: Blakely K, et al.
Publicado: (2016)

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
por: Nicolazzo D, et al.
Publicado: (2014)